-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HPV18-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/331851-78-6.gif)
| Category | Human papillomavirus (HPV) |
| CAS | 331851-78-6 |
| Description | HPV18-IN-1 (Compound H1) is a potent inhibitor of HPV18. HPV18-IN-1 prevents cervical cancer cells from premature cell procession and abnormal proliferation. HPV18-IN-1 supresses E7-Rb-E2F cellular pathway and DNA methylation. HPV18-IN-1 has the potential for the research of cancer diseases. |
Product Information
| Synonyms | HPV18-IN-1|2-(2-amino-1,3-benzothiazol-6-yl)-1,3-benzoxazol-5-amine|CHEMBL4782541|ZINC301733|AKOS003249477|HY-146033|CS-0497870|AK-968/37032067 |
| Molecular Weight | 282.32 |
| Molecular Formula | C14H10N4OS |
| Canonical SMILES | C1=CC2=C(C=C1C3=NC4=C(O3)C=CC(=C4)N)SC(=N2)N |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 371 |
| Exact Mass | 282.05753213 |
| Target | HPV |
| XLogP3-AA | 2.9 |
